Literature DB >> 32393578

The NMDA receptor subunit GluN3A regulates synaptic activity-induced and myocyte enhancer factor 2C (MEF2C)-dependent transcription.

Liang-Fu Chen1, Michelle R Lyons1, Fang Liu1, Matthew V Green1, Nathan G Hedrick1, Ashley B Williams1, Arthy Narayanan1, Ryohei Yasuda2, Anne E West3.   

Abstract

N-Methyl-d-aspartate type glutamate receptors (NMDARs) are key mediators of synaptic activity-regulated gene transcription in neurons, both during development and in the adult brain. Developmental differences in the glutamate receptor ionotropic NMDA 2 (GluN2) subunit composition of NMDARs determines whether they activate the transcription factor cAMP-responsive element-binding protein 1 (CREB). However, whether the developmentally regulated GluN3A subunit also modulates NMDAR-induced transcription is unknown. Here, using an array of techniques, including quantitative real-time PCR, immunostaining, reporter gene assays, RNA-Seq, and two-photon glutamate uncaging with calcium imaging, we show that knocking down GluN3A in rat hippocampal neurons promotes the inducible transcription of a subset of NMDAR-sensitive genes. We found that this enhancement is mediated by the accumulation of phosphorylated p38 mitogen-activated protein kinase in the nucleus, which drives the activation of the transcription factor myocyte enhancer factor 2C (MEF2C) and promotes the transcription of a subset of synaptic activity-induced genes, including brain-derived neurotrophic factor (Bdnf) and activity-regulated cytoskeleton-associated protein (Arc). Our evidence that GluN3A regulates MEF2C-dependent transcription reveals a novel mechanism by which NMDAR subunit composition confers specificity to the program of synaptic activity-regulated gene transcription in developing neurons.
© 2020 Chen et al.

Entities:  

Keywords:  MEF2 transcription factors; NMDAR); N‐methyl‐d‐aspartate receptor (NMDA receptor; brain-derived neurotrophic factor (BDNF); excitation-transcription coupling; gene regulation; glutamate receptor ionotropic NMDA (GluN); ionotropic glutamate receptor; mitogen-activated protein kinase (MAPK) signaling; neurodevelopment; p38 MAPK; synaptic activity

Mesh:

Substances:

Year:  2020        PMID: 32393578      PMCID: PMC7307204          DOI: 10.1074/jbc.RA119.010266

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.486


  55 in total

1.  An NMDA receptor signaling complex with protein phosphatase 2A.

Authors:  S F Chan; N J Sucher
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

2.  Rap2-JNK removes synaptic AMPA receptors during depotentiation.

Authors:  Yinghua Zhu; Daniel Pak; Yi Qin; Stefanie G McCormack; Myung J Kim; Joel P Baumgart; Vanisree Velamoor; Yves P Auberson; Pavel Osten; Linda van Aelst; Morgan Sheng; J Julius Zhu
Journal:  Neuron       Date:  2005-06-16       Impact factor: 17.173

Review 3.  NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease.

Authors:  Pierre Paoletti; Camilla Bellone; Qiang Zhou
Journal:  Nat Rev Neurosci       Date:  2013-06       Impact factor: 34.870

4.  Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior.

Authors:  Zhe-Yu Chen; Deqiang Jing; Kevin G Bath; Alessandro Ieraci; Tanvir Khan; Chia-Jen Siao; Daniel G Herrera; Miklos Toth; Chingwen Yang; Bruce S McEwen; Barbara L Hempstead; Francis S Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

5.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

6.  Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity.

Authors:  Bangmin Zhu; Tod Gulick
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

7.  Requirement for BDNF in activity-dependent survival of cortical neurons.

Authors:  A Ghosh; J Carnahan; M E Greenberg
Journal:  Science       Date:  1994-03-18       Impact factor: 47.728

8.  The transcription factor calcium-response factor limits NMDA receptor-dependent transcription in the developing brain.

Authors:  Michelle R Lyons; Liang-Fu Chen; Jie V Deng; Caitlin Finn; Andreas R Pfenning; Aditi Sabhlok; Kelli M Wilson; Anne E West
Journal:  J Neurochem       Date:  2016-02-15       Impact factor: 5.372

9.  Enhancer Histone Acetylation Modulates Transcriptional Bursting Dynamics of Neuronal Activity-Inducible Genes.

Authors:  Liang-Fu Chen; Yen Ting Lin; David A Gallegos; Mariah F Hazlett; Mariana Gómez-Schiavon; Marty G Yang; Breanna Kalmeta; Allen S Zhou; Liad Holtzman; Charles A Gersbach; Jörg Grandl; Nicolas E Buchler; Anne E West
Journal:  Cell Rep       Date:  2019-01-29       Impact factor: 9.423

10.  Stimulus-specific combinatorial functionality of neuronal c-fos enhancers.

Authors:  Jae-Yeol Joo; Katie Schaukowitch; Lukas Farbiak; Gokhul Kilaru; Tae-Kyung Kim
Journal:  Nat Neurosci       Date:  2015-11-23       Impact factor: 24.884

View more
  2 in total

1.  Mutations of the histone linker H1-4 in neurodevelopmental disorders and functional characterization of neurons expressing C-terminus frameshift mutant H1.4.

Authors:  Martine W Tremblay; Matthew V Green; Benjamin M Goldstein; Andrew I Aldridge; Jill A Rosenfeld; Haley Streff; Wendy D Tan; William Craigen; Nasim Bekheirnia; Saeed Al Tala; Anne E West; Yong-Hui Jiang
Journal:  Hum Mol Genet       Date:  2022-05-04       Impact factor: 5.121

2.  Control of protein synthesis and memory by GluN3A-NMDA receptors through inhibition of GIT1/mTORC1 assembly.

Authors:  María J Conde-Dusman; Partha N Dey; Óscar Elía-Zudaire; Isabel Perez-Otaño; Luis G Rabaneda; Carmen García-Lira; Teddy Grand; Victor Briz; Eric R Velasco; Raül Andero; Sergio Niñerola; Angel Barco; Pierre Paoletti; John F Wesseling; Fabrizio Gardoni; Steven J Tavalin
Journal:  Elife       Date:  2021-11-17       Impact factor: 8.140

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.